NuCana plc (NCNA) Stock Price

1.02 ▼ -0.03 (-2.86%)
Open: 1.02 Vol: 55.15K Day's range: 0.97 - 1.0384 Oct 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NCNA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.06▼ 1.06▼ 1.06▼ 1.06▼ 1.16▼
MA10 1.09▼ 1.09▼ 1.09▼ 1.08▼ 1.34▼
MA20 1.11▼ 1.11▼ 1.10▼ 1.19▼ 1.44▼
MA50 1.10▼ 1.15▼ 1.19▼ 1.34▼ 2.18▼
MA100 1.20▼ 1.26▼ 1.30▼ 1.48▼ 52.32▼
MA200 1.33▼ 1.35▼ 1.35▼ 1.89▼ 1,347.18▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.011▼ -0.007▼ -0.004▼ -0.010▼ 0.362▲
RSI 33.409▼ 34.649▼ 33.674▼ 32.857▼ 31.983▼
STOCH 25.000     25.000     25.000     30.604     13.394▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -85.435▼ -92.476▼
CCI -190.523▼ -186.175▼ -184.261▼ -114.240▼ -150.774▼
Latest Filters Detected On NCNA
▼ GAP $NCNA Open Gap Down %2 Set Alert
CDL $NCNA Doji Candlestick Pattern Detected Set Alert
NuCana plc News
NuCana won a European patent: what it means for NuCana stock
Thursday, October 15, 2026 04:38 AM
NuCana plc (ISIN US67022C3043) won a European patent for its cancer candidate NUC-7738 on September 30, 2026. The patent takes the drug's worldwide protection beyond 85 issued patents, while the ...
NuCana's Encouraging Data From Resistant Melanoma Treatment Provides Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
Monday, September 16, 2024 06:24 AM
On Saturday, NuCana plc (NASDAQ:NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab) ...
NuCana's Encouraging Data From Resistant Melanoma Treatment Provides Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
Monday, September 16, 2024 02:24 AM
On Saturday, NuCana plc (NASDAQ:NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab) ...
NCNA historical stock data
date open high low close volume
15/10/26 1.02 1.0384 0.97 1.02 55,147
14/10/26 1.05 1.065 1.03 1.05 38,043
13/10/26 1.10 1.10 1.05 1.05 51,919
12/10/26 1.10 1.14 1.08 1.08 28,522
09/10/26 1.13 1.18 1.07 1.10 67,336
08/10/26 1.14 1.14 1.10 1.13 34,539
07/10/26 1.09 1.18 1.06 1.14 50,970
06/10/26 1.06 1.14 1.0501 1.09 50,937
05/10/26 1.12 1.12 1.0301 1.06 62,972
02/10/26 1.18 1.22 0.9484 1.09 320,115
Quote Details
52wk Low:0.948
52wk High:5.65
Vol:55.15K
Avg Vol(3m):1.8M
1Y Chng:-74.56%
1M Chng:-28.17%
Add to Watch List
More Information
Index US Composite
Market Cap. 4.14M